TOP TIERMARKET NEWSWIRE
Movers explained · September 18, 2026

Why Is MIRUM PHARMACEUTICAL (MIRM) Stock Moving Today?

By the Top Tier Newswire AI Desk · reviewed against 1 wire stories

MIRUM PHARMACEUTICAL (MIRM) is drawing unusual attention today. Our newswire has captured 1 story on MIRM across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 58/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

The written analysis for MIRM publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.

MIRM by the numbers

7 sessions: -2.11%Coverage: 1 stories / 1 sourcesAI sentiment: 58/100 (bullish)
MIRM · Aug 6 session (5-min) · -13.48% vs prior close · updated 9:44 AM ET
$86.81$96.84$107prev close $105.79$91.537:20 AM7:55 AM8:30 AM9:05 AM9:40 AM7:20 AM · $87.997:25 AM · $87.897:35 AM · $90.007:40 AM · $90.008:05 AM · $91.008:10 AM · $90.258:20 AM · $89.998:25 AM · $90.008:40 AM · $90.498:55 AM · $90.009:00 AM · $90.409:10 AM · $90.009:15 AM · $90.009:20 AM · $90.009:25 AM · $90.359:30 AM · $91.439:35 AM · $91.939:40 AM · $91.53
AI sentiment, last 36h · averaged over 1 story · 58/100 bullish
AI sentiment 58/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowStocktwits News · sentiment 58 · MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?Stocktwits News · 58MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?
19h agoStocktwits NewsBULLISH 58General

MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?

Mirum and Incyte are now awaiting the FDA’s decision on zilurgisertib, a once-a-day pill for an ultra-rare bone disease.

Frequently asked questions

Why is MIRM stock moving today?

MIRUM PHARMACEUTICAL (MIRM) is drawing unusual attention today. Our newswire has captured 1 story on MIRM across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?" (Stocktwits News).

Is MIRM a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of MIRM coverage reads 58/100 over 1 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on MIRM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.